ESR1 and breast carcinoma: Notably, C5AR2 expression levels were diverse in subtypes of breast cancer, and it was much higher in Lumina A and Lumina B (ER-positive) than in HER2 and Basal (ER-negative) in the TIMER2.0 database (Figure S1).